Markel Group (NYSE:MKL) Rating Lowered to Sell at Wall Street Zen

Markel Group (NYSE:MKL) was downgraded by Wall Street Zen from a “buy” rating to a “sell” rating in a research report issued to clients and investors on Saturday.

Several other research analysts have also recently issued reports on the company. Brean Capital started coverage on Markel Group in a research report on Tuesday, March 24th. They issued a “neutral” rating and a $2,100.00 target price on the stock. Zacks Research cut Markel Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, January 19th. Truist Financial dropped their target price on Markel Group from $2,100.00 to $1,950.00 and set a “hold” rating on the stock in a research report on Thursday. Finally, Weiss Ratings cut Markel Group from a “buy (b)” rating to a “hold (c+)” rating in a research report on Wednesday. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $2,025.00.

Markel Group Price Performance

NYSE MKL opened at $1,781.71 on Friday. Markel Group has a one year low of $1,719.41 and a one year high of $2,207.59. The stock has a 50-day moving average of $1,948.66 and a 200 day moving average of $2,019.64. The company has a market capitalization of $22.29 billion, a price-to-earnings ratio of 12.84 and a beta of 0.67. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.63 and a current ratio of 0.63.

Markel Group (NYSE:MKL) last released its quarterly earnings data on Tuesday, April 28th. The insurance provider reported ($18.90) EPS for the quarter, missing the consensus estimate of $26.38 by ($45.28). The business had revenue of $2.82 billion during the quarter, compared to the consensus estimate of $3.66 billion. Markel Group had a return on equity of 7.90% and a net margin of 10.85%. On average, sell-side analysts forecast that Markel Group will post 117.52 EPS for the current year.

Insider Buying and Selling at Markel Group

In other news, CEO Simon Wilson sold 100 shares of Markel Group stock in a transaction dated Thursday, February 26th. The stock was sold at an average price of $2,079.48, for a total transaction of $207,948.00. Following the transaction, the chief executive officer directly owned 2,397 shares of the company’s stock, valued at $4,984,513.56. The trade was a 4.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.08% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in MKL. Valley National Advisers Inc. purchased a new position in shares of Markel Group during the 4th quarter valued at about $25,000. Fideuram Asset Management Ireland dac purchased a new position in shares of Markel Group during the 4th quarter valued at about $26,000. Reflection Asset Management purchased a new position in shares of Markel Group during the 4th quarter valued at about $26,000. Measured Wealth Private Client Group LLC purchased a new position in shares of Markel Group during the 3rd quarter valued at about $29,000. Finally, V Square Quantitative Management LLC purchased a new position in shares of Markel Group during the 4th quarter valued at about $32,000. 77.12% of the stock is owned by hedge funds and other institutional investors.

Markel Group Company Profile

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.